Dr. Islam Mohamed Othman, MD

Dr. Othman practices at Duke Raleigh Hospital - Mammography in Raleigh, North Carolina.

Dr. Othman's NPI, 1700905411, was assigned on March 27, 2007. Dr. Othman holds North Carolina license 2007-01698.

Dr. Othman's primary practice is Duke Raleigh Hospital - Mammography, at 3400 Wake Forest Rd, Raleigh, NC 27609.

Dr. Othman's primary practice is Duke Raleigh Hospital - Mammography in Raleigh, North Carolina. Dr. Othman is also affiliated with WakeMed Raleigh Campus. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Othman to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Othman practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Othman's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Othman is licensed in North Carolina.

CMS data shows 1,187 Medicare services from Dr. Othman across 18 procedure codes in 2024, for 373 Medicare patients. Medicare paid $82,625 for them.

CMS counts 373 Medicare patients who saw Dr. Othman in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Othman's median patient age at 72, with 48% women.

In 2024, Dr. Othman wrote 2,066 Medicare Part D claims for 296 patients. 80% of them were for generic drugs. CMS names the drug for 1,891 of them, across 28 drugs with 11 or more claims each, at $413,385 in total drug cost. In 2023, CMS named 1,734 claims across 31 drugs.

Dr. Othman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Othman as offering telehealth. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Othman, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Othman, published from 2017 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Coronary Artery Disease, Drug-Eluting Stents and Drug Therapy, Combination. Dr. Othman has published most often in Am J Cardiol. Dr. Othman's most frequent co-authors are Dominic J. Allocco, MD, Wayne B. Batchelor, MD and Osvaldo Steven Gigliotti, MD.

Dmand AI links Dr. Othman to 2 clinical trials. Conditions studied include Atherosclerosis and Coronary Artery Disease. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 179 general payments to Dr. Othman from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $93,124.